FTX008762
Sarcopenia and GLP-1 agonist-induced lean tissue atrophy
PreclinicalActive
Key Facts
Indication
Sarcopenia and GLP-1 agonist-induced lean tissue atrophy
Phase
Preclinical
Status
Active
Company
About Fountain Therapeutics
Fountain Therapeutics is a private, preclinical-stage biotech founded in 2018 and based in San Francisco. It utilizes an AI/ML-driven discovery platform to identify novel therapeutic targets for age-related conditions, with two lead programs: a topical treatment for skin atrophy and an oral therapy for muscle atrophy. The company is led by renowned aging researcher Dr. Thomas Rando and co-founder Dr. Joseph T. Rodgers, positioning it at the intersection of geroscience and computational drug discovery. Its business model is focused on developing proprietary therapeutics.
View full company profile